Therese Bittermann, MD, MSCE
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Research Non-Traditional Personnel (NTP), Division of Gastroenterology, Hepatology and Nutrition,
Department of Pediatrics,
Children's Hospital of Philadelphia,
Philadelphia, PA
Research Without Compensation (WOC) appointment, Division of Gastroenterology,
Department of Medicine,
Corporal Michael J. Crescenz VA Medical Center,
Philadelphia, PA
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Medical Director, Living Donor Liver Transplant Program,
Penn Transplant Institute,
University of Pennsylvania
Associate Member, NIH P30 Center for Molecular Studies in Digestive and Liver Disease
Research Associate, NIH P30 Population Aging Research Center
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Fax: 215-349-5915
Education:
BA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent linkBA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Description of Clinical Expertise
I care for patients with viral hepatitis, auto-immune diseases of the liver, fatty liver disease, liver tumors, and cirrhosis. I also have expertise in pre- and post-transplantation management.Description of Research Expertise
I study the relationship between immunosuppression strategy and outcomes after liver transplantation. I have previous expertise in research related to organ allocation, the effects of transplant policymaking and center variability in patient care. I have an advanced degree in clinical epidemiology, and have expertise with observational study designs, large databases and statistics.Selected Publications
Bittermann T: The Potential Synergy of Using Interventional and Observational Data to Study Clinically Meaningful, Long-term Outcomes in Rare Liver and Luminal Diseases. Gastroenterology 163(6): 1491-2, Nov 2022.Mataya L, Bittermann T, Quarshie WO, Griffis H, Srinivasan V, Rand EB, Alcamo AM: Status 1B designation does not adequately prioritize children with acute-on-chronic liver failure for liver transplantation. Liver Transplantation 28(8): 1288-98, Aug 2022.
Kanneganti M, Olthoff KM, Bittermann T: Impact of Older Donor Age on Recipient and Graft Survival After LDLT: The US Experience. Transplantation 1;107(1):162-171, Aug 2022.
Mettikanont P, Kalluri A, Bittermann T, Phillips N, Loza BL, Rosen M, Siegelman E, Furth E, Abt P, Olthoff K, Shaked A, Hoteit M, Reddy KR.: The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated With Explant Pathology: A Single Center Experience. Journal of Clinical and Experimental Hepatology 12(4): 1048-56, Jul-Aug 2022.
Bittermann T, Mahmud N, Weinberg EM, Reddy KR.: Rising trend in waitlisting for alcoholic hepatitis with more favorable outcomes than other high Model for End-stage Liver Disease in the current era. Transplantation 106(7): 1401-1410, Jul 2022.
Bittermann T, Lewis JD, Levy C, Goldberg DS.: Sociodemographic and georaphic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis. Hepatology Epub ahead of print, Jul 2022.
Emamaullee J, Heimbach JK, Olthoff KM, Pomfret EA, Roberts JP, Selzner N; NALLDIG Consortium*.: Assessment of long-term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data. American Journal of Transplantation 22(6): 1519-22, Jun 2022.
Bittermann T, Lewis JD, Goldberg DS: Recipient and center factors associated with immunosuppression practice beyond the first year after liver transplantation and impact on outcomes. Transplantation 1;106(11):2182-2192, Jun 2022.
Panchal S, Serper M, Bittermann T, Asrani SK, Goldberg DS, Mahmud N.: Impact of Race-Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver-Kidney Transplantation. Liver Transplantation 28(6): 959-68, Jun 2022.
Fox AN, Liapakis A, Batra R, Bittermann T, Emamaullee J, Emre S, Genyk Y, Han H, Jackson W, Pomfret E, Raza M, Rodriguez-Davalos M, Rubman Gold S, Samstein B, Shenoy A, Taner T, Roberts JP; North American Living Liver Donor Innovations Group (NALLDIG).: The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidance. Hepatology 75(6): 1579-89, Jun 2022.